Howard W. Robin - Feb 20, 2024 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
President & CEO, Director
Signature
Mark A. Wilson, Attorney-in-Fact
Stock symbol
NKTR
Transactions as of
Feb 20, 2024
Transactions value $
-$13,622
Form type
4
Date filed
2/22/2024, 08:16 PM
Previous filing
Dec 15, 2023
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTR Common Stock Sale -$13.6K -20K -2.23% $0.68 880K Feb 20, 2024 Direct F1, F2
holding NKTR Common Stock 410 Feb 20, 2024 by spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
F2 This transaction was executed in multiple trades at prices ranging from $0.66 to $0.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.